Sequana Medical NV operates within the Commercial physical research sector. In addition to historical fundamental analyses, the complete report available to purchase compares Sequana Medical NV with three other miscellaneous service companies in Europe: Physiomics PLC of UNITED KINGDOM (2020 sales of £799,055.00 [US$1.09 million] of which 100% was Outsourced Systems and Computational Bio), Read-Gene SA of POLAND (4.05 million Polish New Zlotys [US$1.03 million] ), and Inno-Gene SA which is also based in POLAND (4.68 million Polish New Zlotys [US$1.19 million] ).

Sales Analysis. Sales levels dropped significantly in the second quarter of 2021 versus the previous year's second quarter. During the second quarter of 2021, sales at Sequana Medical NV totalled 22,500.00 Euro. This is a drop of 96.2% from the 594,655.00 Euro in sales at the company during the second quarter in 2020. During the year ended December of 2020, sales at Sequana Medical NV were 963,280.00 Euro (US$1.13 million). This is a decrease of 0.8% versus 2019, when the company's sales were 970,636.00 Euro.